Blocking the P2X7 receptor could inhibit inflammatory pathways, regulate growth factor expression, and modulate proteins involved in cell-cell communication, presenting a promising therapeutic avenue for AMD management [53]. The gene discussed is P2RX7; the disease is age-related macular degeneration.